Check patentability & draft patents in minutes with Patsnap Eureka AI!

Heteroaromatic ring compound and application thereof

A compound and heteroaromatic ring technology, applied in the field of heteroaromatic ring compounds, can solve the problems of strong drug-resistant bacteria, weakened antibiotic inhibitory effect, and increased side effects of antibiotics in medical costs

Inactive Publication Date: 2021-07-06
ORIMOS THERAPEUTICS CO LTD
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] With the emergence of drug-resistant bacteria, the inhibitory effect of antibiotics on drug-resistant bacteria is weakened. For this, increasing the dosage of antibiotics is often used clinically to control the infection of drug-resistant bacteria. However, increasing the dosage of antibiotics not only It leads to increased medical costs and side effects of antibiotics, and further leads to the emergence of more resistant bacteria. Therefore, increasing the dosage of antibiotics cannot achieve the desired antibacterial treatment effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Heteroaromatic ring compound and application thereof
  • Heteroaromatic ring compound and application thereof
  • Heteroaromatic ring compound and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0192] The preparation of embodiment 1 compound I-A

[0193]

[0194] Step (1): Synthesis of Compound B2

[0195]

[0196] To a solution of compound B1 (2.0 g, 11.4 mmol) in THF (30 mL) was added isoindoline-1,3-dione (2.52 g, 17.1 mmol), PPh3 (4.49 g, 17.1 mmol) in an ice-water bath and DIAD (3.46 g, 17.1 mmol), the reaction mixture was stirred overnight at room temperature. Then the reaction mixture was washed with H 2 O (30 mL) was diluted and extracted with ethyl acetate (30 mL x 2). The combined organic layers were washed with brine (50 mL), Na 2 SO 4 Dry, filter and concentrate. The residue was purified by reverse-phase silica gel column chromatography (acetonitrile / H 2 O=5%-95%, 254nm, 30min), to obtain compound B2 (2.68g) as a white solid.

[0197] MS calculated: 304; MS found: 305 [M+H] + .

[0198] Step (2): Synthesis of Compound B3

[0199]

[0200] To a solution of compound B2 (2.68 g, 8.81 mmol) in ethanol (20 mL) was added HCl / ethanol (20 mL), ...

Embodiment 2

[0244] The preparation of embodiment 2 compound I-B

[0245]

[0246] Step (1): Synthesis of Compound 2

[0247]

[0248] SEM: (trimethylsilyl)ethoxymethyl.

[0249] Compound 1-2 (0.50 g, 4.7 mmol) and K were added to a solution of compound 1 (1.0 g, 3.1 mmol) in DMF (10 mL). 2 CO 3 (1.28 g, 9.3 mmol). The reaction mixture was stirred at 120 °C for 1 h. The reaction mixture was washed with H 2 O (30 mL) was diluted and extracted with ethyl acetate (30 mL x 2). The combined organic layers were washed with brine (50 mL), washed with Na 2 SO 4 Dry, filter and concentrate. The residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=10 / 1) to obtain Compound 2 (0.6 g) as a yellow oil.

[0250] MS (mass spec) calculated: 426; MS found: 427 [M+H] + .

[0251] Step (2): Synthesis of Compound 3

[0252]

[0253] Jones reagent (2 mL) was added to compound 2 (0.55 g, 1.3 mmol) in acetone (10 mL), the reaction mixture was stirred at room...

Embodiment 3

[0276] The preparation of embodiment 3 compound I-C

[0277]

[0278] Step (1): Synthesis of Compound 2

[0279]

[0280] SEM: (trimethylsilyl)ethoxymethyl.

[0281] Compound 1-2 (0.29 g, 2.3 mmol) and K were added to a solution of compound 1 (0.5 g, 1.6 mmol) in DMF (10 mL). 2 CO 3 (0.66g, 4.8mmol), the reaction mixture was stirred at 120°C for 1h. Then the reaction mixture was washed with H 2 O (30 mL) was diluted and extracted with ethyl acetate (30 mL x 2). The combined organic layers were washed with brine (50 mL), Na 2 SO 4 After drying, filtering and concentrating, the residue was purified by silica gel column chromatography (petroleum ether / ethyl acetate=10 / 1) to obtain compound 2 (0.45 g) as a yellow solid.

[0282] MS calculated: 443; MS found: 444 [M+H] + .

[0283] Step (2): Synthesis of Compound 3

[0284]

[0285] To a solution of compound 2 (0.45 g, 1.0 mmol) in EtOH (10 mL) was added Fe (568.8 mg, 10.1 mmol) and NH 4 Cl (543.5mg, 10.1mmol), ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a heteroaromatic ring compound and application thereof. Specifically, the invention provides a compound shown as a formula I, or an optical isomer or raceme thereof, or a pharmaceutically acceptable salt thereof. The compound provided by the invention can significantly enhance the antibacterial effect of antibiotics, thereby reducing the dosage of antibiotics and reducing the generation of bacterial drug resistance.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a heteroaromatic compound and its application. Background technique [0002] Due to the clinical and non-clinical abuse of antibiotics, the antibacterial activity of antibiotics has decreased, drug-resistant bacteria have emerged, and infections caused by drug-resistant bacteria have become increasingly serious. Antibiotic resistance is considered to be the greatest threat to the treatment of infectious diseases. [0003] With the emergence of drug-resistant bacteria, the inhibitory effect of antibiotics on drug-resistant bacteria is weakened. For this, increasing the dosage of antibiotics is often used clinically to control the infection of drug-resistant bacteria. However, increasing the dosage of antibiotics not only It will lead to increased medical costs and side effects of antibiotics, and will further lead to the emergence of more resistant bacteria. Therefore, increasing the dosa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D498/08C07D498/18C07D471/18C07D487/18A61P31/04A61K31/439A61K31/529A61K31/496
CPCC07D498/08C07D498/18C07D471/18C07D487/18A61P31/04A61K31/439A61K31/529A61K31/496C07B2200/07A61K2300/00
Inventor 张军波朱曙灏齐晓昕
Owner ORIMOS THERAPEUTICS CO LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More